All sponsors

Kind Pharmaceuticals LLC

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING4
READOUTS ≤12 MONTHS3
Open Kind Pharmaceuticals LLC on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
AND017 capsules
NCT07494409
P3RecruitingAnemia Due to Chronic Kidney Disease3002026-10-30
AND017 capsules
NCT06302491
P2Recruitingβ -Thalassemia642026-12 (+12 mo)
AND017
NCT06304103
P2RecruitingMyelodysplastic Syndromes632026-12
AND017
NCT07487727
P3RecruitingAnemia Due to Chronic Kidney Disease2402026-12-01
AND017
NCT06075030
P2Not yet recruitingChemotherapy Induced Anemia362027-12 (+36 mo)
AND017
NCT06075043
P2Not yet recruitingCancer-Related Anemia362028-05 (+40 mo)